Company Nymox Pharmaceutical Corporation

Equities

NYMXF

BSP733981026

Biotechnology & Medical Research

Delayed OTC Markets 09:30:24 2024-03-28 am EDT 5-day change 1st Jan Change
0.36 USD -14.29% Intraday chart for Nymox Pharmaceutical Corporation -10.00% -38.98%

Business Summary

Nymox Pharmaceutical Corporation is a Canada-based biopharmaceutical company focused on developing its drug candidate, NX-1207, for treating benign prostatic hyperplasia (BPH) and low-grade localized prostate cancer. The Company’s activities and resources have been directed primarily at developing certain pharmaceutical technologies. Its products include Fexapotide Triflutate, NicAlert and TobacAlert. Fexapotide Triflutate is a protein injectable for benign prostatic hyperplasia (BPH) and for low grade localized prostate cancer. NicAlert is a simple test to determine smoking status. TobacAlert is a home test that provides an on-the-spot determination of a person’s level of exposure to tobacco products, including secondhand smoke. The Company started two pivotal double-blind placebo-controlled Phase III trials for NX-1207, NX02-0017 and NX02-0018, conducted at investigational sites across the United States with a total enrollment of approximately 1,000 patients.

Managers

Managers TitleAgeSince
Chief Executive Officer 73 95-05-29
Director/Board Member - 23-07-11
Director/Board Member - 23-03-20
Corporate Officer/Principal - -
General Counsel - 20-02-05

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 06-06-07
Chief Executive Officer 73 95-05-29
Director/Board Member 88 15-06-30
Director/Board Member - 23-03-20
Director/Board Member - 23-07-11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 93,265,000 54,049,529 ( 57.95 %) 0 57.95 %

Shareholders

NameEquities%Valuation
38,533,010 42.22 % 20 M $
4,782,065 5.240 % 3 M $
925,000 1.014 % 490 250 $
Gofen & Glossberg LLC
0.0274 %
25,000 0.0274 % 13 250 $
CFS Management Ltd.
0.0259 %
23,631 0.0259 % 12 524 $
BDO Wealth Advisors LLC
0.005150 %
4,700 0.005150 % 2 491 $
Manulife Investment Management Ltd.
0.002229 %
2,034 0.002229 % 1 078 $
David S. Morse
0.000434 %
396 0.000434 % 210 $
Steward Financial Group LLC
0.000110 %
100 0.000110 % 53 $
M. Cutler
0.000000 %
0 0.000000 % - $

Company contact information

Nymox Pharmaceutical Corp.

Bay & Deveaux Streets 2nd Floor

, Nassau

+

http://www.nymox.com
address Nymox Pharmaceutical Corporation(NYMXF)